| Doreen Perez Mondelo, MD | |
|
400 Patroon Creek Blvd Ste 100, Albany, NY 12206-5014 | |
| (518) 618-1100 | |
| Not Available |
| Full Name | Doreen Perez Mondelo |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 400 Patroon Creek Blvd Ste 100, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174830863 | NPI | - | NPPES |
| 187YS1 | Other | NY | EMPIRE BCBS |
| 03464019 | Medicaid | NY | |
| 9635885 | Other | NY | AETNA |
| 120821000140 | Other | NY | FIDELIS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 265445 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eddy Visiting Nurse & Rehab Association | Troy, NY | Home health agency |
| Community Hospice, Inc, The | Rensselaer, NY | Hospice |
| St Peter's Hospital | Albany, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Peter's Health Partners Medical Associates, P.c. | 6103061189 | 393 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Scientists have found a new way of joining groups of atoms together into shape-changing molecules - opening up the possibility of a new area of chemistry and the development of countless new drugs, microelectronics and materials with novel characteristics.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.
› Verified 9 days ago
| Entity Name | Ctp Newton Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801851829 PECOS PAC ID: 1456339639 Enrollment ID: O20040713000954 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Scientists have found a new way of joining groups of atoms together into shape-changing molecules - opening up the possibility of a new area of chemistry and the development of countless new drugs, microelectronics and materials with novel characteristics.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.
› Verified 9 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Scientists have found a new way of joining groups of atoms together into shape-changing molecules - opening up the possibility of a new area of chemistry and the development of countless new drugs, microelectronics and materials with novel characteristics.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.
› Verified 9 days ago
| Entity Name | Hospitalist Healthcare Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275962011 PECOS PAC ID: 1557599313 Enrollment ID: O20140124001195 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Scientists have found a new way of joining groups of atoms together into shape-changing molecules - opening up the possibility of a new area of chemistry and the development of countless new drugs, microelectronics and materials with novel characteristics.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.
› Verified 9 days ago
| Entity Name | New York General Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700315538 PECOS PAC ID: 7810255494 Enrollment ID: O20180103003151 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Scientists have found a new way of joining groups of atoms together into shape-changing molecules - opening up the possibility of a new area of chemistry and the development of countless new drugs, microelectronics and materials with novel characteristics.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Doreen Perez Mondelo, MD Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-5634 | Doreen Perez Mondelo, MD 400 Patroon Creek Blvd Ste 100, Albany, NY 12206-5014 Ph: (518) 618-1100 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Scientists have found a new way of joining groups of atoms together into shape-changing molecules - opening up the possibility of a new area of chemistry and the development of countless new drugs, microelectronics and materials with novel characteristics.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.
› Verified 9 days ago
Dr. Terrence Flannery, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Patroon Creek Blvd, Albany, NY 12206 Phone: 518-641-3217 Fax: 518-641-3209 | |
Pascuala C Reyes, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 113 Holland Ave, Albany, NY 12208 Phone: 518-626-5000 | |
Dr. Lorelei A Michels, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 638 Western Ave, Albany, NY 12203 Phone: 518-763-3312 Fax: 518-489-4040 | |
David A Robinson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 315 S Manning Blvd, @ St. Peter's Hospital Er Dept., Albany, NY 12208 Phone: 518-525-1324 Fax: 518-383-4223 | |
Dr. Peter Alexander Vellis, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 Washington Ave, Albany, NY 12222 Phone: 518-442-5461 Fax: 518-442-5444 | |
Dr. Dan Richard Tobin, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Albany, NY 12208 Phone: 518-626-6125 | |
Jonathan Peter Teubl, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 |